SKU: CB1620

CHO-K1 OKT3 PD-L1

Regular price
£2,000.00
Sale price
£2,000.00
Regular price
Tax included.
Out of Stock

A CHO-K1 cell line expressing a CD3 targeting TCR activator and human PD-L1. Can be used in conjunction with the Jurkat PD-1 NFAT-luciferase cell line for the screening of combinations of PD-1/PD-L1 antagonists.

FOR RESEARCH USE ONLY

RoukenCells product packaging on a light gray background
Graph comparing PD-L1 expression between CHO-K1 WT and CHO-K1 OKT PD-L1 cell lines.
Graph showing luminescence (RLU) against Nivolumab concentration on a log scale.
  • RoukenCells product packaging on a light gray background
  • Graph comparing PD-L1 expression between CHO-K1 WT and CHO-K1 OKT PD-L1 cell lines.
  • Graph showing luminescence (RLU) against Nivolumab concentration on a log scale.
RoukenCells product packaging on a light gray background
Graph comparing PD-L1 expression between CHO-K1 WT and CHO-K1 OKT PD-L1 cell lines.
Graph showing luminescence (RLU) against Nivolumab concentration on a log scale.
Specification
Target/Receptor
OKT3 TCR activator
PD-L1
Aliases
N/A
CD274, B7-H1, Programmed death ligand 1
Uniprot ID
N/A
Q9NZQ7
Receptor Species
N/A
Homo sapiens
Response Element
None
Reporter
None
Cell Line Background
CHO-K1
Target Information and Further Details
This CHO-K1 cell line stably expresses human PD-L1 (Programmed Cell Death 1 Ligand 1, PDCD1 Ligand 1) and a membrane bound OKT3 anti-CD3 scFv TCR activator. When co-cultured with Jurkat NFAT PD-1 (RoukenCells #CB1589), activation of NFAT can be quantitatively assessed through luciferase activity, providing a robust and sensitive readout for pathway stimulation. PD-L1 expression has been confirmed by flow cytometry, and the cell line has been functionally validated in co-culture assays.
Performance Data
Graph comparing PD-L1 expression between CHO-K1 WT and CHO-K1 OKT PD-L1 cell lines.

Figure 1. PD-L1 expression profile (orange) compared to wild-type (grey).

Graph showing luminescence (RLU) against Nivolumab concentration on a log scale.

Figure 2. PD-1 blocking assay with Nivolumab (50 – 0.001 ng/mL). Jurkat NFAT PD-1 reporter cells co-cultured with CHO-K1 OKT3 PD-L1 5:1 E:T

Shipping Details

Supplied as 1 vial of >3 million viable cells.

* Please note that US import permits for CHO-K1 cell products are the responsibility of the US-based recipient/importer. RoukenCells is happy to provide supporting documentation (e.g. product descriptions and noninfectious statements) to assist with the import process.

Cell Line Datasheet

Access detailed product specifications, user guides and technical documentation in PDF format.

Download PDF

Related products

Take a moment to explore selections tailored just for you.

Explore Now